Jennifer Dittman - 16 May 2024 Form 3 Insider Report for Third Harmonic Bio, Inc. (THRD)

Role
Chief Development Oper Officer
Signature
/s/ Christopher Murphy, Attorney-in-Fact
Issuer symbol
THRD
Transactions as of
16 May 2024
Net transactions value
$0
Form type
3
Filing time
20 May 2024, 16:32:17 UTC
Next filing
22 May 2024
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
holding THRD Employee Stock Option (right to buy) 16 May 2024 Common Stock 26,800 $10.89 Direct F1
holding THRD Employee Stock Option (right to buy) 16 May 2024 Common Stock 23,700 $4.20 Direct F2
holding THRD Employee Stock Option (right to buy) 16 May 2024 Common Stock 50,000 $4.30 Direct F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The option vests over a four-year period: 1/48th on February 5, 2024, after which 1/48th of the total shares vest monthly, subject to continued service through each vesting date.
F2 The option vests over a four-year period: 1/48th on April 6, 2023, after which 1/48th of the total shares vest monthly, subject to continued service through each vesting date.
F3 25% of the total shares vest on December 19, 2023, and thereafter 2.08333% of the total shares underlying the award shall vest in equal monthly installments until fully vested, subject to the Reporting Person's continued service to the Issuer on each vesting date.